Skip to Main Content

Paper Details

Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth.
J Clin Invest
20
2021
AR, AR cistromes, AR complexes, DHT, GRHL2, HOXB13, MYC oncoprotein, PC, PC models, Prostate cancer, advanced PC, androgen, androgen receptor, androgens, cachexia, cancer, castration, castration-sensitive and castration-resistant PC, dihydrotestosterone, muscle wasting, prostate, prostate cancer, steroidal androgens, testosterone
Author NameAffiliation
Alexandra Corella
Ilsa Coleman
Eva Corey
Stephen R Plymateand Clinical Center
Stephen R PlymateUniversity of Washington
Michael C Haffner
Michael C HaffnerDivision of Clinical Research, Fred Hutchinson Cancer Research Center
Elahe A Mostagheland Clinical Center
Elahe A MostaghelUniversity of Washington
Elahe A MostaghelDivision of Clinical Research, Fred Hutchinson Cancer Research Center
Peter S Nelson
Peter S Nelson
Peter S NelsonUniversity of Washington
Peter S NelsonDivision of Clinical Research, Fred Hutchinson Cancer Research Center
Peter S Nelson
Peter S Nelson
Peter S NelsonUniversity of Washington
Peter S NelsonDivision of Clinical Research, Fred Hutchinson Cancer Research Center
  • 1 - 18

Datasets

Release 1.2